Your browser doesn't support javascript.
loading
K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
Nussinov, Ruth; Muratcioglu, Serena; Tsai, Chung-Jung; Jang, Hyunbum; Gursoy, Attila; Keskin, Ozlem.
Affiliation
  • Nussinov R; a Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research , National Cancer Institute at Frederick , Frederick , MD , USA.
  • Muratcioglu S; b Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.
  • Tsai CJ; c Department of Chemical and Biological Engineering , Koc University , Istanbul , Turkey.
  • Jang H; a Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research , National Cancer Institute at Frederick , Frederick , MD , USA.
  • Gursoy A; a Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research , National Cancer Institute at Frederick , Frederick , MD , USA.
  • Keskin O; d Department of Computer Engineering , Koc University , Istanbul , Turkey.
Expert Opin Ther Targets ; 20(7): 831-42, 2016 Jul.
Article in En | MEDLINE | ID: mdl-26873344

Full text: 1 Database: MEDLINE Main subject: Adenocarcinoma / Molecular Targeted Therapy / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Expert Opin Ther Targets Journal subject: TERAPEUTICA Year: 2016 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Adenocarcinoma / Molecular Targeted Therapy / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Expert Opin Ther Targets Journal subject: TERAPEUTICA Year: 2016 Type: Article Affiliation country: United States